Mr. John McMullen reports

GLOBAL CANNA LABS FORMALLY RECEIVES TIER 3 CULTIVATING LICENSE TO GROW MEDICAL CANNABIS IN JAMAICA

LGC Capital Ltd. investment Global Canna Labs Ltd. (GCL) has formally received its Tier 3 cultivation licence from the Jamaican Cannabis Licensing Agency (CLA). The licence allows the company to cultivate organic medical cannabis at its 270,000-square-foot facility within its 6.23-acre site in Montego Bay, Jamaica.

Pursuant to its licence, GCL has commenced planting 8,000 seedlings for its first cycle. The first harvest is anticipated in Q4 2018. GCL has also started the expansion of its current growing facility in Montego Bay. GCL is committed to achieving its GGAP (Global Good Agricultural Procedures), GMP (Good Manufacturing Practices) and GMP EU (Good Manufacturing Practices -- European Union) certifications in months to come.

GCL is also working toward the acquisition of an additional 300 acres of land in Jamaica. LGC will update the market as this development is finalized.

John McMullen, chief executive officer of LGC, stated: "I would like to congratulate the GCL team. Receiving this licence instantly adds value to the company and demonstrates the expertise and abilities of the GLC management team. LGC is honoured to be partnering with GLC, which is positioning itself as a leader in the Jamaican cannabis industry and being an active member of the team as it sets its sites on the rest of legal cannabis world."

Paul Glavine, president of GCL, states: "I would like to thank the GCL team for their dedication and hard work. I am excited about what the future brings as the real work begins now."

About LGC Capital Ltd.

LGC's objective is to become a diversified business group with core business divisions that provide shareholders with exposure to a diverse range of businesses, products and services with an emphasis on significant investments in global medical cannabis sector.

We seek Safe Harbor.